Journals / Gülhane Tıp Dergisi / 2016 / Cilt: 58 - Sayı: 4

Laparoscopic sentinel lymph node mapping with indocyanin green for endometrium cancer: First experience within university hospitals in Turkey

Endometrium kanserinde indosiyanin yeşili ile laparoskopik sentinel lenf nodu haritalaması: Türkiye üniversite hastanelerinde ilk deneyim

Pages
424–426
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In here, we are proud to report the first experience of sentinel lymph node mapping with indocyanin green in endometrium cancer, among all Turkish university hospitals.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Laparoscopic sentinel lymph node mapping with indocyanin green for endometrium cancer: First experience within university hospitals in Turkey Sentinel lymph node mapping (SLNM) is a novel and newly developing minimally invasive surgical option for surgical staging of endometrial cancer built for avoidance of unnecessary total lymphadenectomy and its possible complications.
📊
Key Findings & Data:Indocyanin green is considered as one of the most effective methods used for sentinel lymph node mapping in endometrial cancer.
💡
Conclusion & Impact:In here, we are proud to report the first experience of sentinel lymph node mapping with indocyanin green in endometrium cancer, among all Turkish university hospitals.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Laparoscopic sentinel lymph node mapping with indocyanin green for endometrium cancer: First experience within university hospitals in Turkey Sentinel lymph node mapping (SLNM) is a novel and newly developing minimally invasive surgical option for surgical staging of endometrial cancer built for avoidance of unnecessary total lymphadenectomy and its possible complications. Indocyanin green is considered as one of the most effective methods used for sentinel lymph node mapping in endometrial cancer. In here, we are proud to report the first experience of sentinel lymph node mapping with indocyanin green in endometrium cancer, among all Turkish university hospitals.

Özet

Sentinel lenf nodu haritalaması, endometrium kanserinde komplet lenfadenektominin muhtemel komplikasyonlarına hastayı maruz bırakmaksızın, cerrahi evreleme olanağı sağlayan yeni ve halen gelişmekte olan minimal invaziv bir cerrahi seçenektir. Lenf nodu haritalaması esnasında indosiyanin yeşili kullanımının bu amaçla kullanılan diğer yöntemlerden daha etkin ve başaralı klinik sonuçlar sunduğu düşünülmektedir. Bu vaka sunumu, Türkiye üniversite hastanelerinde ilk kez uygulanan indosiyanin yeşili ile laparaskopik sentinel lenf nodu haritalama prosedürünü raporlamak ve elde edilen cerrahi deneyimi paylaşmak amacı ile düzenlenmiştir

🔖

Cite This Article

DEDE, M., BODUR, S., FİDAN, U., YENEN, M. C., FIRATLIGİL, F. B. (2016). Laparoscopic sentinel lymph node mapping with indocyanin green for endometrium cancer: First experience within university hospitals in Turkey. Gülhane Tıp Dergisi, Cilt: 58 - Sayı: 4, 424–426. https://ajindex.com/articles/189776

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ.Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg1992;127:392–399
  2. Cody HS, Hill AD, Tran KN, Borgen PI. Credentialing for breast lymphatic mapping: how manycases are eno￾ugh? Ann Surg 1999;229:723–728
  3. Van der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment ofearly-stage vulvar cancer. J Clin Oncol 2008;26(6):884–894
  4. How J, Gotlieb WH, Press JZ, Abitbol J, Pelmus M, Fe￾renczy A, Probst S, Gotlieb R, Brin S, Lau S. Comparing indocyanine green, technetium, and blue dye for senti￾nel lymph node mapping in endometrial cancer. Gyne￾col Oncol. 2015 Jun;137(3):436-442
  5. Creasman W, Odicino F, Maisonneuve P, et al., “Car￾cinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer,” International Journal of Gynecology and Obstetrics, vol. 95, supplement 1, pp. S105–S143, 2006
  6. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, and Heller PB. “Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study,” Cancer, vol. 60, supplement 8, pp. 2035– 2041, 1987
  7. Boente MP, Yordan Jr. EL, McIntosh DG, et al., “Prog￾nostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement,” Gynecolo￾gic Oncology, vol. 51, no. 3, pp. 316–322, 1993
  8. Abu-Rustum NR. Sentinel lymph node mapping for en￾dometrial cancer: a modern approach to surgical sta￾ging. J Natl Compr Canc Netw. 2014 Feb;12(2):288-97
  9. Morrow CP, Bundy BN, Kurman RJ, et al., “Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study,” Gynecologic Oncology, vol. 40, no. 1, pp. 55–65, 1991
  10. Garg G, Morris RT, Solomon L, et al., “Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endomet￾rial cancer,” Gynecologic Oncology, vol. 123, no. 2, pp. 208–213, 2011
  11. Querleu, F. Planchamp, F. Narducci et al., “Clinical practice guidelines for the management of patients with endometrial cancer in france recommendations of the institut national du cancer and the société frança￾ise d'oncologie gynécologique,” International Journal of Gynecological Cancer, vol. 21, no. 5, pp. 945–950, 2011
  12. Ballester M, Dubernard G, Lécuru F, et al., “Detection rate and diagnostic